Your browser doesn't support javascript.
loading
Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases.
Weißenberg, Sarah Y; Szelinski, Franziska; Schrezenmeier, Eva; Stefanski, Ana-Luisa; Wiedemann, Annika; Rincon-Arevalo, Hector; Welle, Anna; Jungmann, Annemarie; Nordström, Karl; Walter, Jörn; Imgenberg-Kreuz, Juliana; Nordmark, Gunnel; Rönnblom, Lars; Bachali, Prathyusha; Catalina, Michelle D; Grammer, Amrie C; Lipsky, Peter E; Lino, Andreia C; Dörner, Thomas.
Afiliación
  • Weißenberg SY; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Szelinski F; German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany.
  • Schrezenmeier E; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Stefanski AL; German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany.
  • Wiedemann A; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Rincon-Arevalo H; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Welle A; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Jungmann A; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Nordström K; German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany.
  • Walter J; Grupo de Inmunología Celular e Inmunogenética, Facultad de Medicina, Instituto de Investigaciones Médicas, Universidad de Antioquia UdeA, Medellín, Colombia.
  • Imgenberg-Kreuz J; Department of Genetics and Epigenetics, Saarland University, Saarbrücken, Germany.
  • Nordmark G; Department of Genetics and Epigenetics, Saarland University, Saarbrücken, Germany.
  • Rönnblom L; Department of Genetics and Epigenetics, Saarland University, Saarbrücken, Germany.
  • Bachali P; Department of Genetics and Epigenetics, Saarland University, Saarbrücken, Germany.
  • Catalina MD; Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Grammer AC; Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Lipsky PE; Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Lino AC; RILITE Research Institute, Charlottesville, VA, United States.
  • Dörner T; RILITE Research Institute, Charlottesville, VA, United States.
Front Immunol ; 10: 2136, 2019.
Article en En | MEDLINE | ID: mdl-31616406
ABSTRACT
Autoimmune diseases (AID) such as systemic lupus erythematosus (SLE), primary Sjögren's syndrome (pSS), and rheumatoid arthritis (RA) are chronic inflammatory diseases in which abnormalities of B cell function play a central role. Although it is widely accepted that autoimmune B cells are hyperactive in vivo, a full understanding of their functional status in AID has not been delineated. Here, we present a detailed analysis of the functional capabilities of AID B cells and dissect the mechanisms underlying altered B cell function. Upon BCR activation, decreased spleen tyrosine kinase (Syk) and Bruton's tyrosine kinase (Btk) phosphorylation was noted in AID memory B cells combined with constitutive co-localization of CD22 and protein tyrosine phosphatase (PTP) non-receptor type 6 (SHP-1) along with hyporesponsiveness to TLR9 signaling, a Syk-dependent response. Similar BCR hyporesponsiveness was also noted specifically in SLE CD27- B cells together with increased PTP activities and increased transcripts for PTPN2, PTPN11, PTPN22, PTPRC, and PTPRO in SLE B cells. Additional studies revealed that repetitive BCR stimulation of normal B cells can induce BCR hyporesponsiveness and that tissue-resident memory B cells from AID patients also exhibited decreased responsiveness immediately ex vivo, suggesting that the hyporesponsive status can be acquired by repeated exposure to autoantigen(s) in vivo. Functional studies to overcome B cell hyporesponsiveness revealed that CD40 co-stimulation increased BCR signaling, induced proliferation, and downregulated PTP expression (PTPN2, PTPN22, and receptor-type PTPs). The data support the conclusion that hyporesponsiveness of AID and especially SLE B cells results from chronic in vivo stimulation through the BCR without T cell help mediated by CD40-CD154 interaction and is manifested by decreased phosphorylation of BCR-related proximal signaling molecules and increased PTPs. The hyporesponsiveness of AID B cells is similar to a form of functional anergy.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Linfocitos B Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Linfocitos B Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article País de afiliación: Alemania